Advanced Cell Technology gets $25 million from investor
Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical trials. The funding commitment came from Socius Capital Group subsidiary Socius CG II Ltd. and is comprised of a $25 million non-convertible stock purchase agreement. The agreement stipulates […]